Home » Topics » BioWorld Science

BioWorld Science
RSS

iTeos Therapeutics presents adenosine A2A receptor antagonists

April 23, 2020

Antabio SAS divulges Pseudomonas aeruginosa elastase inhibitors

April 23, 2020

Takeda Pharmaceutical discloses new GIPR agonists

April 23, 2020

Alpha Cognition signs up CRO to support development of Alpha-1062 for Alzheimer's

April 23, 2020

GRP78 does not predict bortezomib response in patients with multiple myeloma

April 23, 2020

Polymer-linked rotigotine shows promise in patients with PD

April 23, 2020

Cheating cell death improves post-infarct heart function

April 23, 2020

Truncating DNVs in the last exon of SEMA6B causes progressive myoclonic epilepsy

April 23, 2020

Positive data presented from phase III SPIRIT 2 study of relugolix combination therapy

April 23, 2020

Phase II study of vixarelimab in prurigo nodularis meets primary efficacy endpoint

April 23, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026